AbCellera Biologics Inc. (22) | Business Operations (2)
- Form of Director and Officer Indemnification Agreement (Filed With SEC on December 7, 2020)
- Research Collaboration and License Agreement between the Registrant and Eli Lilly and Company, dated March 11, 2020 (Filed With SEC on November 20, 2020)